Clinical trial Recruiting at 1 site Interventional Ages 8 to 13

3D printed reverse twin block to treat Class III malocclusion in growing kids

Official title: Effectiveness of a Novel 3D Printed Reverse Twin Block in The Management of Maxillary Deficiency of Class III Malocclusion: A Randomized Clinical Trial

Run by University of Baghdad · NCT07710391 · Data updated 2026-11-12

This trial tests whether a 3D-printed reverse twin block can better correct maxillary deficiency in children with Class III alignment compared with the conventional appliance over six months.

More Class II Malocclusion trials

Quick facts

Study typeInterventional
Ages8 Years to 13 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of Baghdad
Academic / other
Locations1 site (Baghdad)
StatusRecruiting
StartedJune 10, 2026
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedJuly 21, 2026
Trial IDNCT07710391 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Growing children aged 8–13 with mixed dentition, residual maxillary growth, and Class III tendency with anterior crossbite or reverse overjet are ideal candidates.

Probably not a fit

Patients without remaining maxillary growth or without a Class III pattern may see limited to no benefit from the 3DRTB.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares a novel 3D printed reverse twin block (3DRTB) with the conventional reverse twin block (CRTB) for correcting sagittal discrepancies due to maxillary deficiency in growing patients with Class III malocclusion. Participants are 8- to 13-year-olds with mixed dentition and remaining maxillary growth, assigned to either 3DRTB or CRTB for a 6-month treatment period. Outcomes include sagittal, transverse, and vertical jaw relationships, soft tissue profile, incisor inclination, patient perception via questionnaire, and oral hygiene impact. Primary focus is the effectiveness of 3DRTB in improving sagittal discrepancy; secondary aims cover morphology, aesthetics, and patient-reported experience. The study uses cephalometric criteria and clinical assessments to compare the two appliances.

Why it matters

Potential benefit: If successful, the 3DRTB could provide a more effective, patient-friendly option for correcting Class III malocclusion in growing children.

How similar studies have gone: Prior work with reverse twin blocks shows benefit for similar conditions, but this specific 3D-printed approach is being tested for added effectiveness and patient experience.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. The age group selected is mixed dentition group 8-13 years with residual potential maxillary growth. Patient maturity will be assessed using the Cervical Vertebral Maturation (CVM) method on lateral cephalogram, patients in CS1-CS3 stages will be included to ensure remaining maxillary growth.
2. Presence of permanent first molar with lower anterior teeth to retain the appliance.
3. Skeletal/dental class III tendency with anterior cross bite or reverse overjet: a. Clinically the overjet is equal or less than zero up to -3 mm.

   b. Cephalometric ANB angle equal or less than zero up to -3 degrees and Wits appraisal ≤ -2.
4. Prescence of unilateral or bilateral posterior crossbite.
5. Mild to moderate anterior crowding.
6. Acceptable oral hygiene baseline defined by oral hygiene index (OHI). -

Exclusion Criteria:

1. Patients with cleft lip and palate and/or craniofacial anomalies.
2. History of previous orthopedic and/or orthodontic treatment.
3. Presence of uncontrolled systemic disease or medically compromised status.
4. Uncooperative patient/parents.

Where it's running

  • Collage of Dentistry, University of Baghdad
    Baghdad, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.